Send this to a friend

Biostage failed to meet NASDAQ requirements

Biostage will be delisted from the NASDAQ stock market if it loses an upcoming appeal, after the company failed to raise its bid price to $1 within a given 180-day period.
The Holliston company said it received a letter from NASDAQ on May 18, saying its failure to reach the $1 bid price requirement, and its non-compliance with the $2.5 million stockholders’ equity requirement as of the quarter ended Back to article

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media